Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 1Aventis Pharma Deutschland GmbH Frankfurt Am Main DE
01 1Protirelin
01 1France
01 1Expired
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Certificate Number : R1-CEP 1997-057 - Rev 00
Status : Expired
Issue Date : 2004-05-25
Type : Chemical and TSE
Substance Number : 1144
20
Aventis Pharma Deutschland Gmbh Frankfurt Am Main De, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their significant offerings is Protirelin, supported by a 'Expired' Certificate of Suitability (CEP) with the number R1-CEP 1997-057 - Rev 00
This Chemical and TSE Type CEP, issued on May 25, 2004, remains in force until May 25, 2009, ensuring its reliability within the pharmaceutical industry.
Substance Number 1144 associated with this CEP further emphasizes
LOOKING FOR A SUPPLIER?